Thread‐Designed Vascular Scaffold with Magneto‐Optical Probes Capture and Elimination of Circulating Tumor Cells In Vivo

L LiHua Guo (State Key Laboratory on Integrated Optoelectronics College of Electronic Science and Engineering Jilin University Changchun P. R. China) R RuiLin Lou (State Key Laboratory on Integrated Optoelectronics College of Electronic Science and Engineering Jilin University Changchun P. R. China) J Jiekai Lyu (State Key Laboratory on Integrated Optoelectronics College of Electronic Science and Engineering Jilin University Changchun P. R. China) X Xin Xu Z Zhifang Wang (Department of Chemistry, Institute of Molecular Aggregation Science, School of Science) L Lin Xu (Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.) J Jiao Sun N Nan Shi B Biao Dong

Abstract

ABSTRACT Metastasis, responsible for over 90% of cancer‐related deaths, is largely fueled by circulating tumor cells (CTCs). Although eliminating CTCs could inhibit metastasis, the complex in vivo environment makes it difficult. Considerable progress of in vitro CTCs detection has been made, yet its translation into effective in vivo systems, particularly for large animals, continues to pose a substantial challenge. This study introduces a threaded vascular scaffold that creates a cell‐enrichment zone by modulating radial fluid velocity, enhancing cell axiality and providing an optimized environment for CTCs capture. In addition, hybrid membranes‐modified magnetic beads (HM‐MBs) loaded with indocyanine green and coated with tumor‐white cell membranes, enabling specific recognition and binding of CTCs. Under external magnetic guidance, CTCs bound to HM‐MBs are efficiently accumulated at the scaffold site, followed by near‐infrared light‐triggered activation of photodynamic and photothermal effects for targeted CTCs elimination. This integrated system effectively addresses key challenges in in vivo CTCs detection and removal. Experimental results in rabbit and goat vessels demonstrated high capture efficiencies of 60.3% and 54.7%, respectively, along with post‐irradiation elimination rates exceeding 90%. This integrated approach enables targeted in vivo CTCs capture and destruction, disrupting the metastatic cascade and offering a promising strategy for adjuvant cancer therapy.

Article Details

Volume / Issue Vol. 38, Issue 12
Published February 01, 2026
ISSN 0935-9648
Publisher Unknown Publisher

Journal Info

Advanced Materials

Unknown Publisher

ISSN: 0935-9648 Physical Sciences

Authors (9)

L

LiHua Guo

State Key Laboratory on Integrated Optoelectronics College of Electronic Science and Engineering Jilin University Changchun P. R. China

R

RuiLin Lou

State Key Laboratory on Integrated Optoelectronics College of Electronic Science and Engineering Jilin University Changchun P. R. China

J

Jiekai Lyu

State Key Laboratory on Integrated Optoelectronics College of Electronic Science and Engineering Jilin University Changchun P. R. China

X

Xin Xu

Z

Zhifang Wang

Department of Chemistry, Institute of Molecular Aggregation Science, School of Science

L

Lin Xu

Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.

J

Jiao Sun

N

Nan Shi

B

Biao Dong